allogeneic natural killer cells

BIOLOGICAL3 trials

Sponsors

Masonic Cancer Center, University of Minnesota, Tianjin First Central Hospital

Conditions

Fallopian Tube CancerLeukemiaLymphomaOvarian CancerPeritoneal Cavity CancerSmall Cell Lung Cancer

Phase 1

Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

TerminatedNCT00625729

Masonic Cancer Center, University of MinnesotaLeukemia, Lymphoma

Start: 2008-01-31End: 2010-04-30Updated: 2017-12-28

Phase 2

Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer

TerminatedNCT00652899

Masonic Cancer Center, University of MinnesotaFallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer

Start: 2008-03-31End: 2009-08-31Updated: 2017-12-28

NK Cells Plus ICI for SCLC Maintenance

RecruitingNCT07759856

Tianjin First Central HospitalSmall Cell Lung Cancer

Start: 2026-08-01End: 2029-08-01Target: 42Updated: 2026-08-12

Related Papers

APOLLO: A phase I study of adaptive memory natural killer (NK) cells in recurrent ovarian cancer.

Journal of Clinical Oncology2020-05-207 citations